HomeTagsGeneral Catalyst

General Catalyst

Stories from General Catalyst come first, newest first, then stories from connected topics (Funding, Hub: AI Funding, AI Funding & Deals, AI funding, energy, AI), each labelled with where it comes from. This view is not indexed by search engines.

Re:Build Secures $2.1bn Led by General Catalyst and JPMorganChase

Re:Build, the US manufacturer that incubated Slate, says it has secured $2.1bn led by General Catalyst and JPMorganChase. No valuation was given.

Just in

Latest

WashU Makes Edible Fungal Protein From Waste CO2

WashU researchers made edible fungal protein from waste CO2 in a lab-scale One Earth study. The 48.5% protein biomass is not yet a commercial product.

NIH-Backed Endometriosis Genomics Study Finds 58 Regions

An NIH-backed endometriosis genomics study of over 1 million people finds 58 regions in Nature Genetics. It is an association study, not a test or treatment.

UK Rooftop Solar Breaks Its Annual Record With Six Weeks Left

About 270,000 UK rooftop solar installations have already beaten the 2025 annual record, with six weeks of 2026 left, official MCS and DESNZ figures show.

Berkeley GPCPI Reads Label-Free Optical Cell Fingerprints

UC Berkeley’s GPCPI reads label-free optical fingerprints of skin cell lines in a lab test reported in Optica. It is a proof of concept, not a diagnostic.

Alpöge’s Riemann Hypothesis Claim Passes Most Lean Checks

Alpöge says he and Claude have a Riemann hypothesis proof. Most MIT Lean checks passed, but a comparator run is still in progress and there is no paper.

CUHK’s RhoAgent Virtual Scientist Designs Working RNA

CUHK’s RhoAgent designed working RNA in lab tests, Nature Biotechnology reports. The results are laboratory findings, not a therapy.

ECMWF Starts Forecast-in-a-Box Weather Pilot in Malawi

ECMWF is piloting Forecast-in-a-Box in Malawi with MET Norway and DCCMS. It is a portable AI weather system in a pilot, with no published accuracy figures.

Nature Cancer Publishes THREADS Pathology Foundation Model

Mass General Brigham’s THREADS pathology model is published in Nature Cancer after a Jan 2025 preprint. It is a research result, not a clinical product.

Senate Passes Data-Centre Grid Cost Bill, House Still to Vote

The US Senate has passed a bipartisan 62-33 bill that would raise data-centre grid costs. It still needs the House before any new charges take effect.

AWS Says Cairn AI Agents Found and Exploited a Zero-Day

Amazon says a Chinese-nexus actor's Cairn AI agents found and exploited a zero-day on their own. AWS rates that finding high confidence.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.